Houlihan Lokey, Inc. (HLI)
NYSE: HLI · Real-Time Price · USD
146.44
+8.44 (6.12%)
At close: Nov 2, 2026, 4:00 PM EST
145.50
-0.94 (-0.64%)
After-hours: Nov 2, 2026, 7:30 PM EST
Houlihan Lokey Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Houlihan Lokey stock has a consensus rating of "Buy" and an average price target of $161.44. The average 1-year stock price forecast is 10.24% higher than the current stock price, while the lowest is $153 (+4.48%) and the highest is $175 (+19.50%).
Price Target: $161.44 (+10.24%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Houlihan Lokey stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 5 | 6 | 6 | 6 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Reiterates $150 → $162 | Buy | Reiterates | $150 → $162 | +10.63% | Nov 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $165 | Buy | Reiterates | $165 | +12.67% | Oct 29, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $147 → $153 | Hold | Maintains | $147 → $153 | +4.48% | Oct 29, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $153 → $164 | Buy | Maintains | $153 → $164 | +11.99% | Oct 29, 2026 |
| KBW | KBW | Buy Reiterates $150 → $155 | Buy | Reiterates | $150 → $155 | +5.85% | Oct 29, 2026 |
Financial Forecast
Revenue This Year
2.72B
from 2.62B
Increased by 3.85%
Revenue Next Year
3.13B
from 2.72B
Increased by 15.06%
EPS This Year
7.28
from 7.56
Decreased by -3.73%
EPS Next Year
8.70
from 7.28
Increased by 19.55%
EPS and Forward PE are based on non-GAAP adjusted numbers.